Supernus Pharmaceuticals | Des Atouts



Assets Changement Date
Abbott USD 81.45B 34M 2025-03
ANI Pharmaceuticals USD 1.28B 3.68M 2024-12
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Eisai JPY 1.43T 111.45B 2024-12
Eli Lilly USD 89.39B 10.67B 2025-03
Indivior 1.38B 56M 2025-03
Novo Nordisk 489.16B 91.72B 2025-03
Pacira USD 1.55B 31.82M 2024-12
Perrigo USD 9.76B 112.1M 2025-03
Pfizer USD 208.03B 5.37B 2025-03
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
United Therapeutics USD 7.74B 379.9M 2025-03
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12



Supernus Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.